Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials

Overview of attention for article published in Radiotherapy & Oncology, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 4,932)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 86 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 105 X posts from 86 X users, with an upper bound of 140,659 followers.

🚨 NSABP B-51: no benefit to RNI in cN+ -> ypN0 breast cancer following neoadj systemic therapy. Findings consistent with our secondary pooled analysis for HER2+ breast cancer. https://t.co/scECRjJJrd

08 Dec 2023

Reply Repost Favourite

RT @wtarscott: Rethink PMRT in clinical N+ to ypN0 in HER2+ breast cancer? …

03 Sep 2023

Reply Repost Favourite

RT @toddscarbrough: Late tweet better than no tweet at all… When will it become SOP to not post mastectomy irradiate pCR N+ HER2? Need a…

13 Jul 2023

Reply Repost Favourite

RT @toddscarbrough: Late tweet better than no tweet at all… When will it become SOP to not post mastectomy irradiate pCR N+ HER2? Need a…

12 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 101 additional X posts.